Group B Streptococcus disease during infancy and risk of subsequent neurodevelopmental impairments in young children: a population-based cohort study in Ontario, CanadaResearch in context

Summary: Background: Group B Streptococcus (GBS) is a leading infectious cause of neonatal morbidity and mortality worldwide, yet data on longer-term outcomes in children remain limited. We aimed to assess the risk of neurodevelopmental impairments (NDIs) in GBS survivors and to explore effect modi...

Full description

Bibliographic Details

Published in:	The Lancet Regional Health. Americas
Main Authors:	Romina Fakhraei, Deshayne B. Fell, Darine El-Chaâr, Nisha Thampi, Beate Sander, Kevin Antoine Brown, Natasha Crowcroft, Shelly Bolotin, Jon Barrett, Elizabeth K. Darling, Nahuel Fittipaldi, Theresa Lamagni, Allison McGeer, Michelle Murti, Manish Sadarangani, Kevin L. Schwartz, Abdool Yasseen, Matthew Tunis, William Petrcich, Kumanan Wilson
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Subjects:	Group B Streptococcus Streptococcus agalactiae Neurodevelopmental impairments Effect modification Sex differences Prematurity
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667193X25001802